Market Cap

Prelude Therapeutics Incorporated Market Capitalization:

$44.8 Million

USD as of July 1, 2025

business Prelude Therapeutics Incorporated Company Profile

Prelude Therapeutics Incorporated Main Stock Listing

NASDAQ: PRLD

Market Capitalization History of Prelude Therapeutics Incorporated

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $309.91 B
Vertex Pharmaceuticals Incorporated $117.36 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $59.14 B
Marinomed Biotech AG $58.56 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Yearly evolution of Prelude Therapeutics Incorporated market cap

Date Market Cap YoY Change
Jan. 1, 2025 $64.4 M -68.93%
Jan. 1, 2024 $207.3 M -30.02%
Jan. 1, 2023 $296.2 M -31.92%
Jan. 1, 2022 $435.1 M -84.71%
Jan. 1, 2021 $2.85 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Prelude Therapeutics Incorporated Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Prelude Therapeutics Incorporated has the following listings and related stock indices.


Stock: NASDAQ: PRLD

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.